Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

New Antimicrobial Agents in Respiratory Medicine

호흡기 내과의사를 위한 치료약제의 최신지견 - 항생제

  • Chung, Moon-Hyun (Department of Internal Medicine, Inha University School of Medicine)
  • 정문현 (인하대학교 의과대학 내과학교실)
  • Published : 2006.01.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Delgado G Jr, Neuhauser MM, Bearden DT, Danziger LH. Quinupristin-dalfopristin: an overview. Pharmacotherapy 2000;20:1469-85 https://doi.org/10.1592/phco.20.19.1469.34858
  2. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003;138:135-42 https://doi.org/10.7326/0003-4819-138-2-200301210-00015
  3. Steenbergen JN, Alder J, Thorne GM, Tally FP. Daptomycin: a lipopeptide antibiotic for the treatment of serious gram-positive infections. J Antimicrob Chemother 2005;55:283-8 https://doi.org/10.1093/jac/dkh546
  4. Lewis JS 2nd, Owens A, Cadena J, Sabol K, Patterson JE, Jorgensen JH, et al. Emergence of daptomycin resistance in enterococcus faecium during daptomycin therapy. Antimicrob Agents Chemother 2005;49:1664-5 https://doi.org/10.1128/AAC.49.4.1664-1665.2005
  5. Montecalvo MA. Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients. J Antimicrob Chemother 2003;51(Suppl 3):iii31-5
  6. Malabarba A, Goldstein BP. Origin, structure, and activity in vitro and in vivo of dalbavancin. J Antimicrob Chemother 2005;55(Suppl 2):ii15-20 https://doi.org/10.1093/jac/dki005
  7. Fritsche TR, Kirby JT, Jones RN. In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections. Diagn Microbiol Infect Dis 2004;49:201-9 https://doi.org/10.1016/j.diagmicrobio.2003.12.002
  8. Postier RG, Green SL, Klein SR, Ellis-Grosse EJ, Loh E. Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients. Clin Ther 2004;26:704-14 https://doi.org/10.1016/S0149-2918(04)90070-7
  9. Roos K, Tellier G, Baz M, Leroy B, Rangaraju M. Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis. J Infect 2005;50:210-20 https://doi.org/10.1016/j.jinf.2004.05.014
  10. Aubier M, Aldons PM, Leak A, McKeith DD, Leroy B, Rangaraju M, et al. Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis. Respir Med 2002;96:862-71 https://doi.org/10.1053/rmed.2001.1207
  11. Fogarty CM, Kohno S, Buchanan P, Aubier M, Baz M. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriologic efficacy of the ketolide telithromycin. J Antimicrob Chemother 2003;51:947-55 https://doi.org/10.1093/jac/dkg153
  12. Perry CM, Ibbotson T. Biapenem. Drugs 2002;62: 2221-34 https://doi.org/10.2165/00003495-200262150-00005
  13. Shah PM, Isaacs RD. Ertapenem, the first of a new group of carbapenems. J Antimicrob Chemother 2003; 52:538-42 https://doi.org/10.1093/jac/dkg404
  14. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005;9:R53-9 https://doi.org/10.1186/cc3020
  15. Jimenez-Mejias ME, Pichardo-Guerrero C, Marquez-Rivas FJ, Martin-Lozano D, Prados T, Pachon J. Cerebrospinal fluid penetration and pharmacokinetic/ pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 2002;21:212-4 https://doi.org/10.1007/s10096-001-0680-2
  16. Benifla M, Zucker C, Cohen A, Alkan M. Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E. J Antimicrob Chemother 2004;54: 290-2 https://doi.org/10.1093/jac/dkh289
  17. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003;36:630-7 https://doi.org/10.1086/367933
  18. Denning DW. Echinocandin antifungal drugs. Lancet 2003;362:1142-1151 https://doi.org/10.1016/S0140-6736(03)14472-8
  19. Mora-Durik J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002;347:2020-9 https://doi.org/10.1056/NEJMoa021585
  20. Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventinal antifungal therapy. Clin Infect Dis 2004;39:1563-71 https://doi.org/10.1086/421088
  21. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363-73 https://doi.org/10.1056/NEJMra050740